
Radio and PodcastLive Radio & Podcasts
The Lenacapavir Partnership and the Evolution of U.S. Foreign Assistance The Futures Summit
In September 2025, the U.S. Department of State, Gilead Sciences, and the Global Fund to Fight AIDS, Tuberculosis and Malaria announced a novel partnership to procure and deliver lenacapavir—a groundbreaking twice-yearly...
About This Episode
The Lenacapavir Partnership and the Evolution of U.S. Foreign Assistance The Futures Summit is an episode from Take as Directed by CSIS Global Health Policy Center | Center for Strategic and International Studies. In September 2025, the U.S...
This episode belongs to Take as Directed.
Use the player on this page to stream the episode online.
Published May 5, 2026, 72:41 long, audio available.
Questions About This Episode
What is The Lenacapavir Partnership and the Evolution of U.S. Foreign Assistance The Futures Summit about?
In September 2025, the U.S. Department of State, Gilead Sciences, and the Global Fund to Fight AIDS, Tuberculosis and Malaria announced a novel partnership to procure and deliver lenacapavir—a groundbreaking twice-yearly injectable pre-exposure prophylaxis (PrEP) for HIV prevention—to up to two million people over next three years. On Tuesday, April 14, the leadership of these three entities convened to discuss the partnership now that doses have begun to arrive in country and have been delivered. Katherine E. Bliss, Director of Immunizations and Health Systems Resilience and Senior Fellow with the CSIS Global Health Policy Center moderated the conversation with Jeremy P. Lewin, Senior Official for the Office of the Under Secretary for Foreign Assistance, Humanitarian Affairs, and Religious Freedom at the U.S. Department of State; Daniel O’Day, Chairman and CEO of Gilead Sciences; and Peter Sands, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. Together they examined how this deal fits into a renewed U.S. strategy for foreign assistance focused on big bets and advancing American innovations around the world, what challenges lie on the horizon as implementation unfolds, and what additional innovations may accelerate scaling this effort.
Where can I listen to The Lenacapavir Partnership and the Evolution of U.S. Foreign Assistance The Futures Summit?
You can listen to The Lenacapavir Partnership and the Evolution of U.S. Foreign Assistance The Futures Summit online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is The Lenacapavir Partnership and the Evolution of U.S. Foreign Assistance The Futures Summit from?
The Lenacapavir Partnership and the Evolution of U.S. Foreign Assistance The Futures Summit is an episode from Take as Directed by CSIS Global Health Policy Center | Center for Strategic and International Studies.
How long is this episode?
This episode is 72:41 long.
When was this episode published?
This episode was published on May 5, 2026.
Can I save The Lenacapavir Partnership and the Evolution of U.S. Foreign Assistance The Futures Summit for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from Take as Directed?
Yes. This page shows related episodes from Take as Directed when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to The Lenacapavir Partnership and the Evolution of U.S. Foreign Assistance The Futures Summit?
You can listen to The Lenacapavir Partnership and the Evolution of U.S. Foreign Assistance The Futures Summit on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
The Lenacapavir Partnership and the Evolution of U.S. Foreign Assistance The Futures Summit is from Take as Directed by CSIS Global Health Policy Center | Center for Strategic and International Studies.
What are the episode details?
Published May 5, 2026 and 72:41 long